Cargando…

Tolcapone in Obsessive Compulsive disorder: A Randomized Double-Blind Placebo-Controlled Crossover Trial

OBJECTIVE: Despite the availability of evidence-based treatments for obsessive-compulsive disorder (OCD), not all patients experience sufficient benefit or are able to tolerate them. Tolcapone is a catechol-o-methyl-transferase (COMT) enzyme inhibitor that augments cortical dopaminergic transmission...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grant, Jon E., Hook, Roxanne, Valle, Stephanie, Chesivoir, Eve, Chamberlain, Samuel R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7611531/ https://www.ncbi.nlm.nih.gov/pubmed/34310432 http://dx.doi.org/10.1097/YIC.0000000000000368

Ejemplares similares

A Double-Blind, Placebo-Controlled Study of Brexpiprazole in the Treatment of Borderline Personality Disorder
por: Grant, Jon E., et al.
Publicado: (2022)

Temperament in trichotillomania and skin picking disorder
por: Grant, Jon E., et al.
Publicado: (2023)

Topiramate augmentation in refractory obsessive-compulsive disorder: A randomized, double-blind, placebo-controlled trial
por: Afshar, Hamid, et al.
Publicado: (2014)

Repetitive transcranial magnetic stimulation over the orbitofrontal cortex for obsessive-compulsive disorder: a double-blind, crossover study
por: Nauczyciel, C, et al.
Publicado: (2014)

Safety, tolerability, and clinical and neural effects of single-dose psilocybin in obsessive–compulsive disorder: protocol for a randomized, double-blind, placebo-controlled, non-crossover trial
por: Ching, Terence H. W., et al.
Publicado: (2023)

Obsessive‐compulsive disorder: Etiology, neuropathology, and cognitive dysfunction
por: Jalal, Baland, et al.
Publicado: (2023)

Suicidal Ideation and Attempts in Trichotillomania
por: Grant, Jon E., et al.
Publicado: (2023)

Efficacy of N-Acetylcysteine Augmentation on Obsessive Compulsive Disorder: A Multicenter Randomized Double Blind Placebo Controlled Clinical Trial
por: Ghanizadeh, Ahmad, et al.
Publicado: (2017)

Prevalence of Obsessive-Compulsive Spectrum Disorders in Obsessive-Compulsive Disorder
por: Siddiqui, Mohammad Aleem, et al.
Publicado: (2018)

Obsessive-compulsive symptoms and the Covid-19 pandemic: A rapid scoping review
por: Grant, Jon E., et al.
Publicado: (2022)

Quetiapine augmentation of SRIs in treatment refractory obsessive-compulsive disorder: a double-blind, randomised, placebo-controlled study [ISRCTN83050762]
por: Carey, Paul D, et al.
Publicado: (2005)

Quetiapine augmentation of SRIs in treatment refractory obsessive-compulsive disorder: a double-blind, randomised, placebo-controlled study [ISRCTN83050762]
por: Carey, Paul D, et al.
Publicado: (2005)

Granisetron-mediated augmentation of sertraline therapeutic effect in obsessive-compulsive disorder: a double-blind placebo-controlled, randomized clinical trial
por: Ghobadian, Ala, et al.
Publicado: (2022)

Memantine for Refractory Obsessive-Compulsive Disorder: Protocol for a Pragmatic, Double-blind, Randomized, Parallel-Group, Placebo-Controlled, Monocenter Trial
por: Maraone, Annalisa, et al.
Publicado: (2023)

Agomelatine augmentation of sertraline in the treatment of moderate to severe obsessive-compulsive disorder: a randomized double-blinded placebo-controlled clinical trial
por: Shokrani, Marjan, et al.
Publicado: (2023)

Transformation obsessions in Obsessive-Compulsive Disorder
por: Sharma, Pooja, et al.
Publicado: (2022)

Transformation obsessions in Obsessive-Compulsive Disorder
por: Sharma, Pooja, et al.
Publicado: (2022)

Clinical advances in obsessive-compulsive disorder: a position statement by the International College of Obsessive-Compulsive Spectrum Disorders
por: Fineberg, Naomi A., et al.
Publicado: (2020)

Perceived Stress in Obsessive–Compulsive Disorder is Related with Obsessive but Not Compulsive Symptoms
por: Morgado, P., et al.
Publicado: (2013)

Gambling disorder and obsessive–compulsive personality disorder: A frequent but understudied comorbidity
por: Medeiros, Gustavo C., et al.
Publicado: (2018)

Antipsychotic Augmentation of Serotonin Reuptake Inhibitors in Treatment-Resistant Obsessive-Compulsive Disorder: An Update Meta-Analysis of Double-Blind, Randomized, Placebo-Controlled Trials
por: Dold, Markus, et al.
Publicado: (2015)

Utility of tolcapone in fluctuating Parkinson’s disease
por: Stocchi, Fabrizio, et al.
Publicado: (2006)

Relationship between severity of obsessive-compulsive symptoms and schizotypy in obsessive-compulsive disorder
por: Yamamoto, Haruka, et al.
Publicado: (2012)

A comparison of symptom dimensions for obsessive compulsive disorder and obsessive compulsive-related disorders
por: Say Öcal, Derya, et al.
Publicado: (2019)

An analysis of the prevalence and impact of obsessive-compulsive personality disorder on the course of obsessive-compulsive disorder
por: Żerdziński, M., et al.
Publicado: (2023)

Obsessive Compulsive Symptoms, Obsessive Compulsive Disorder and Related Disorders in Idiopathic Parkinson’s Disease
por: Çakıroğlu, E., et al.
Publicado: (2023)

Placebo Effect in Obsessive-Compulsive Disorder (OCD). Placebo Response and Placebo Responders in OCD: The Trend Over Time
por: Kotzalidis, Georgios D., et al.
Publicado: (2019)

Memantine augmentation of sertraline in the treatment of symptoms and executive function among patients with obsessive-compulsive disorder: A double-blind placebo-controlled, randomized clinical trial
por: Askari, Sanaz, et al.
Publicado: (2022)

Memantine augmentation of sertraline in the treatment of symptoms and executive function among patients with obsessive-compulsive disorder: A double-blind placebo-controlled, randomized clinical trial
por: Askari, S.
Publicado: (2023)

CATATONIA IN OBSESSIVE COMPULSIVE DISORDER
por: Jagadheesan, K., et al.
Publicado: (2002)

Epilepsy and obsessive-compulsive disorder
por: Kaplan, Peter W.
Publicado: (2010)

Superstitiousness in obsessive-compulsive disorder
por: Brugger, Peter, et al.
Publicado: (2010)

Obsessive-compulsive spectrum disorders
por: Allen, Andrea, et al.
Publicado: (2003)

Management of Obsessive-Compulsive Disorder
por: Seibell, Phillip J., et al.
Publicado: (2014)

Seasonal obsessive-compulsive disorder
por: Sinha, Prakriti, et al.
Publicado: (2014)

Genetics of obsessive-compulsive disorder
por: Purty, Abhishek, et al.
Publicado: (2019)

Genetics of obsessive-compulsive disorder
por: Mahjani, Behrang, et al.
Publicado: (2021)

Double blind randomized controlled trial of deep brain stimulation for obsessive-compulsive disorder: Clinical trial design
por: McLaughlin, Nicole C.R., et al.
Publicado: (2021)

The Effect of Atorvastatin on Obsessive-compulsive Symptoms of Refractory Obsessive-compulsive Disorder (Add-on Therapy)
por: Akouchekian, Shahla, et al.
Publicado: (2018)

Obsessive-compulsive symptoms in children with first degree relatives diagnosed with obsessive-compulsive disorder
por: Chacon, Priscila, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_2sgmvc1sdd1lagii65emsh6rri